                </a></li></ul></div><p><strong>Figure 2.  <span>Geometric mean anti-AMA49-C1 and anti-UK-39 IgG endpoint titers in ELISA of groups immunized with optimal doses of PEV301 (50 µg) or PEV302 (10 µg), or with 50 µg each of both antigens.</span></strong></p><a id="article1.body1.sec3.sec5.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec5.sec2.fig1.caption1.p1"></a><p>Sera analyzed were collected during the screening visit, at the days of the 2<sup>nd</sup> and 3<sup>rd</sup> vaccination, 21 days after each vaccination and one year after the third vaccination</p>
